SPY321.78+2.86 0.90%
DIA268.52+1.93 0.72%
IXIC10,554.09+65.52 0.62%
新闻
TTPH
--
0.00%
--
Merger Arbitrage Mondays - Dime Community Bancshares And Bridge Bancorp Combine In Merger Of Equals
Seeking Alpha - Article · 07/06 14:11
Merger Arbitrage Mondays - Tetraphase Pharmaceuticals Finds A New Home
Seeking Alpha - Article · 06/29 11:16
The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy
Benzinga · 06/25 13:26
The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24)
Benzinga · 06/25 12:26
La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals, Inc.
GlobeNewswire · 06/24 12:30
La Jolla to acquire Tetraphase Pharma
Seeking Alpha - Article · 06/24 11:53
Tetraphase Terminated Deal With Melinta
Benzinga · 06/24 11:38
UPDATE: Total Value Of La Jolla Purchase Of Tetraphase $43M In Upfront Cash Plus Potential Future Cash Payments Of Up To $16M
Benzinga · 06/24 11:33
UPDATE: Tetraphase Shareholders Will Be Entitled To Receive 1 Non-Tradeable Contingent Value Right
Tetraphase equity holders would also be entitled to receive, for each share of Tetraphase common stock, one non-tradeable CVR. The holders of the CVRs would be entitled to receive payments of up to an additional $16.0
Benzinga · 06/24 11:32
La Jolla Pharma To Purchase Tetraphase Pharma For Upfront Payment Of $2/Share Of Tetraphase Common Stock, $2.68/Share Of Tetraphase Stock Underlying Nov. 2019 Warrants , $2.69/Share Tetraphase Stock Underlying Jan. 2020 Warrants
Benzinga · 06/24 11:31
La Jolla Pharmaceutical Rekindles Interest In Tetraphase With Sweetened Offer
Benzinga · 06/22 17:14
La Jolla Pharmaceutical Rekindles Interest In Tetraphase With Sweetened Offer
The bidding war for Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH) seems to be far from over.
Benzinga · 06/22 16:14
Tetraphase Announces Receipt of Proposal from La Jolla Pharmaceutical Company, Determination of Superior Offer and Notice to Melinta
Business Wire · 06/22 11:00
Merger Arbitrage Mondays - 2 Chinese Companies Choose To Go Private
Seeking Alpha - Article · 06/22 10:38
La Jolla Pharma makes unsolicited bid for Tetraphase Pharma
Seeking Alpha - Article · 06/22 10:33
Tetraphase Pharma Receives an Acquisition Offer From La Jolla Pharma, Tetraphase Board Continues to Recommend Merger with Melinta
Under the Melinta Merger Agreement, Melinta would acquire Tetraphase through a cash tender offer by its subsidiary for all of Tetraphase’s outstanding shares of common stock, for an aggregate of $39.0 million in
Benzinga · 06/22 10:10
Merger Arbitrage Mondays - Simon Property Group Attempts To Walk Away
Seeking Alpha - Article · 06/15 12:29
The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset
Benzinga · 06/10 12:30
Melinta inks agreement for Tetraphase buy
Seeking Alpha - Article · 06/09 20:25
EBS, OPNT among premarket losers
Seeking Alpha - Article · 06/08 13:22